Your browser doesn't support javascript.
loading
Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli.
Bajoria, Sakshi; Antunez, Lorena R; Kumru, Ozan S; Klempner, Mark; Wang, Yang; Cavacini, Lisa A; Joshi, Sangeeta B; Volkin, David B.
Affiliation
  • Bajoria S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA.
  • Antunez LR; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA.
  • Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA.
  • Klempner M; MassBiologics of the University of Massachusetts Chan Medical School, Boston, MA 02126, USA.
  • Wang Y; MassBiologics of the University of Massachusetts Chan Medical School, Boston, MA 02126, USA.
  • Cavacini LA; MassBiologics of the University of Massachusetts Chan Medical School, Boston, MA 02126, USA.
  • Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA.
  • Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA. Electronic address: volkin@ku.edu.
J Pharm Sci ; 112(7): 1832-1844, 2023 07.
Article in En | MEDLINE | ID: mdl-37040833

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli Infections / Enterotoxigenic Escherichia coli Type of study: Health_economic_evaluation Limits: Child / Humans Language: En Journal: J Pharm Sci Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli Infections / Enterotoxigenic Escherichia coli Type of study: Health_economic_evaluation Limits: Child / Humans Language: En Journal: J Pharm Sci Year: 2023 Type: Article Affiliation country: United States